New #1 treatment in its class

AS OF 8/6/2021*

*Per IQVIA as oral brand in class (oral CGRP receptor antagonists): number one
prescribed,
number one in new prescriptions, and more neurologists selected as
brand of choice

patient profiles

Ellie W
Actual Nurtec ODT Patient

Every patient is unique—adapt between acute and preventive

Treat attacks
through 48 hours
Evan experiences ~4 migraine attacks per
month, and is dissatisfied with his current
acute treatments
.

Evan is an actual patient, and is taking or has taken
Nurtec ODT.

Adapt to your patient's
changing needs
Ellie W, Actual Nurtec ODT Patient
Ellie averages 4 migraines per month but
the migraines increase when facing
unavoidable triggers like stress.

Ellie is an actual patient, and is taking or has taken
Nurtec ODT.

Tia's menstrual cycle can be prolonged, lasting
days. Migraines take away her days and time
spent with her family. Her current treatments
are not doing the job
.

Tia is an actual patient, and is taking or has taken
Nurtec ODT.

When preventive
is right
Jennifer has a high potential for migraines
each month and could benefit from a
treatment that is easy to take and puts
her in control of her life
.

Jennifer is an actual patient, and is taking or has taken
Nurtec ODT.

What real patients
are saying about
Nurtec ODT

Showing XX of XX